Open access
Open access
Powered by Google Translator Translator

Coronary Insufficiency

Cohort Study | Association of high‐sensitivity Troponin T and I with mortality and cardiovascular outcomes in stable patients.

26 Sep, 2022 | 11:59h | UTC

Association of High‐Sensitivity Troponin T and I Blood Concentrations With All‐Cause Mortality and Cardiovascular Outcome in Stable Patients—Results From the INTERCATH Cohort – Journal of the American Heart Association

Invited Commentary: Troponin in Stable Patients Undergoing Coronary Angiography: Should It Be Routinely Assessed? – Journal of the American Heart Association

 


RCT | Effect of clinical decision support with audit and feedback on prevention of acute kidney injury in patients undergoing coronary angiography.

22 Sep, 2022 | 13:04h | UTC

Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

Commentary: Intervention Cuts Risk for AKI After Coronary Angiography – HealthDay

 

Commentary on Twitter

 


Long-term follow-up of a RCT | Percutaneous coronary intervention vs. bypass surgery for multivessel coronary artery disease.

20 Sep, 2022 | 13:34h | UTC

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial – Circulation

Commentary: 10-Year Data From BEST Trial Find No Significant Safety or MACE Differences Between PCI With EES Versus CABG – Cardiac Interventions Today

Original Study: Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease – New England Journal of Medicine

 


Study | The specificity and positive predictive value of high-sensitivity cardiac troponin I for the diagnosis of myocardial infarction are reduced in older individuals.

16 Sep, 2022 | 12:57h | UTC

Influence of Age on the Diagnosis of Myocardial Infarction – Circulation

 


Study finds a higher complication rate after acute coronary syndrome in patients with rheumatic immune‐mediated inflammatory diseases.

15 Sep, 2022 | 13:01h | UTC

Outcomes Following Acute Coronary Syndrome in Patients With and Without Rheumatic Immune‐Mediated Inflammatory Diseases – Journal of the American Heart Association

News Release: Study finds higher complication rate after heart attack in people with autoimmune disease – American Heart Association

 


Pregnancy-related acute myocardial infarction: a review of the recent literature.

15 Sep, 2022 | 12:59h | UTC

Pregnancy-related acute myocardial infarction: a review of the recent literature – Clinical Research in Cardiology

 


RCT | A double-dose influenza vaccination during hospitalization for acute coronary syndrome did not improve outcomes compared to standard-dose outpatient vaccination.

13 Sep, 2022 | 13:19h | UTC

Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial – European Heart Journal

 

Commentary on Twitter

 


RCT | Effects of Nicorandil administration on infarct size in patients with ST‐Segment–Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention.

11 Sep, 2022 | 22:37h | UTC

Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial – Journal of the American Heart Association

 


Study suggests many stable patients with ST-Elevation Myocardial Infarction may not require routine admission to a cardiac intensive care unit following PCI reperfusion.

8 Sep, 2022 | 14:45h | UTC

Incidence and Predictors of Adverse Events Among Initially Stable ST‐Elevation Myocardial Infarction Patients Following Primary Percutaneous Coronary Intervention – Journal of the American Heart Association

 


#ESCCongress | Study shows long-term Evolocumab appears to be safe in patients with established atherosclerotic cardiovascular disease.

30 Aug, 2022 | 12:12h | UTC

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease – Circulation

News Release: Long-term evolocumab therapy leads to further reductions in cardiovascular events – European Society of Cardiology

Original Article: Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease – New England Journal of Medicine

 

Commentary on Twitter

 


#ESCCongress – RCT | In patients with severe ischemic left ventricular systolic dysfunction under optimal medical therapy, revascularization by PCI did not improve outcomes.

29 Aug, 2022 | 12:38h | UTC

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Coronary stenting does not benefit patients with severe left ventricular dysfunction – European Society of Cardiology

Commentary: DANCAVAS: CV Screening Did Not Significantly Reduce Incidence of Death in Older Males – American College of Cardiology

 

Commentary on Twitter

 


#ESCCongress – RCT | Routine functional testing is not better than standard care in high-risk patients after percutaneous coronary intervention.

29 Aug, 2022 | 12:32h | UTC

Routine Functional Testing or Standard Care in High-Risk Patients after PCI – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


#ESCCongress | In patients within 6 months of a myocardial infarction, a polypill containing aspirin, ramipril, and atorvastatin resulted in a lower risk of major adverse cardiovascular events compared to usual care.

29 Aug, 2022 | 12:27h | UTC

Polypill Strategy in Secondary Cardiovascular Prevention – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Polypill reduces cardiovascular events in heart attack patients compared to usual care – European Society of Cardiology

Commentaries:

SECURE: Treatment With Polypill Significantly Lowers Risk of Major CV Events – American College of Cardiology

Polypill Strategy Lowers Adverse CV Event Risk in Secondary Prevention – HCPLive

Related: M-A: Polypills with and without aspirin substantially reduce cardiovascular disease, myocardial infarction, stroke, revascularization, and cardiovascular death in primary cardiovascular disease prevention. (several studies on the subject)

 


[News release – not published yet] #ESCCongress – RCT | Allopurinol does not improve cardiovascular outcomes in ischemic heart disease patients.

29 Aug, 2022 | 12:15h | UTC

Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease patients – European Society of Cardiology

Commentary:

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention – TCTMD

No improvement with allopurinol for patients with ischemic heart disease: ALL-HEART – Cardiology Now

 


Vasospastic angina: a contemporary review of its pathophysiology, diagnosis and management.

25 Aug, 2022 | 11:53h | UTC

Vasospastic Angina: A Contemporary Review of its Pathophysiology, Diagnosis and Management – Heart International

 

Commentary on Twitter

 


M-A | Association of dual antiplatelet therapy with ticagrelor with vein graft failure after coronary artery bypass graft surgery.

10 Aug, 2022 | 15:32h | UTC

Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis – JAMA (free for a limited period)

Editorial: Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery – JAMA (free for a limited period)

Author Interview: Coronary Artery Bypass Surgery in 2022 – JAMA

News Release: Two-medication strategy offers both benefit and risk after coronary artery bypass surgery – Weill Cornell Medicine

 


Systematic Review | Smoking cessation for secondary prevention of cardiovascular disease.

9 Aug, 2022 | 12:42h | UTC

Smoking cessation for secondary prevention of cardiovascular disease – Cochrane Library

Summary: Does stopping smoking make people with heart disease less likely to have another heart attack? – Cochrane Library

 


Is the contemporary care of older persons with acute coronary syndrome evidence-based?

8 Aug, 2022 | 11:48h | UTC

Is the contemporary care of the older persons with acute coronary syndrome evidence-based? – European Heart Journal Open

 

Commentary from the author on Twitter

 


RCT | External support for saphenous vein grafts in coronary artery bypass surgery.

26 Jul, 2022 | 11:44h | UTC

External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)

Commentary: In CABG patients, external graft support devices fail to prolong patency of saphenous vein graft: JAMA – Medical Dialogues

 

Commentary on Twitter

 


Open-label RCT | Moderate-intensity statin plus ezetimibe is noninferior to high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease.

20 Jul, 2022 | 12:32h | UTC

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial – The Lancet (link to abstract – $ for full-text)

 


Position Paper | Post-discharge and long-term follow-up after an acute coronary syndrome.

18 Jul, 2022 | 11:22h | UTC

Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper – Archives of Medical Science

 

Commentary on Twitter

 


Coronary Artery Disease Reporting and Data System (CAD-RADS 2.0) reporting system for patients undergoing coronary CT angiography.

14 Jul, 2022 | 12:49h | UTC

CAD-RADSTM 2.0 2022 Coronary Artery Disease – Reporting and Data System An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR) and the North America Society of Cardiovascular Imaging (NASCI) – Journal of Cardiovascular Computed Tomography

Commentary: SCCT Releases New Expert Consensus Document on CAD Reporting – American College of Cardiology

 


Secondary analysis of a RCT | Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk.

11 Jul, 2022 | 12:06h | UTC

Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis – European Heart Journal

Commentaries:

EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity – CardiovascularNews

One-Month DAPT Enough for Complex PCI if Bleeding Risk High – Medscape (free registration required)

 

Commentary on Twitter

 


RCT | Distal radial vs. conventional radial access for coronary angiography and intervention.

5 Jul, 2022 | 11:54h | UTC

Distal Versus Conventional Radial Access for Coronary Angiography and Intervention: The DISCO RADIAL Trial – JACC Cardiovascular Interventions

Editorial: Less Is More, But Not Always: Distal Transradial Access for Radial Artery Occlusion Prevention

Commentaries:

DISCO RADIAL: Distal Radial and Transradial Access Similar When Performed With Rigorous Hemostasis – American College of Cardiology

Distal radial access not better than conventional approach in preventing radial arterial occlusion, DISCO RADIAL Trial – Medical Dialogues

Distal Radial Access Doesn’t Lower Risk of Occlusion: DISCO RADIAL – TCTMD

Fancy Coronary Access Technique Disappoints in Preventing Radial Artery Occlusions — Distal radial approach did result in easier hemostasis, however – MedPage Today (free registration required)

 

Commentary on Twitter


Guideline Synopsis | Evaluation and diagnosis of chest pain.

4 Jul, 2022 | 12:49h | UTC

Evaluation and Diagnosis of Chest Pain – JAMA (free for a limited period)

Original Guideline:

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines – Journal of the American College of Cardiology

News Release: First-Ever Guideline Focused Solely on Chest Pain Evaluation, Diagnosis Released

Guideline Hub: Guideline for the Evaluation and Diagnosis of Chest Pain

Key Points: 2021 AHA/ACC Chest Pain Guideline – American College of Cardiology

Commentary: New Chest Pain Guidelines Out at Last: Most Tests Have a Role – TCTMD


Stay Updated in Your Specialty

No spam, just news.